RT info:eu-repo/semantics/article
T1 Trends in the use of driving-impairing medicines according to the DRUID category: A population-based registry study with reference to driving in a region of Spain between 2015 and 2019
A1 Gutiérrez Abejón, Eduardo
A1 Criado Espegel, Paloma
A1 Pedrosa Naudín, M. Aránzazu
A1 Fernández Lázaro, Diego
A1 Herrera Gómez, Francisco Magno
A1 Álvarez González, Francisco Javier
K1 Automobile driving
K1 Automóviles - Conducción
K1 Drug utilization
K1 Medicamentos - Uso
K1 Pharmacology
K1 Traffic accidents
K1 Accidentes de tráfico
K1 Tráfico - España
K1 Driving-impairing medicines
K1 Medicamentos que afectan la conducción
K1 DRUID classification
K1 3209 Farmacología
K1 3209.03 Evaluación de Medicamentos
AB The European DRUID (Drive Under the Influence of drugs, alcohol, and medicines) program classifies medications into three categories according to their effect on one’s fitness to drive. The trend in the use of driving-impairing medicines (DIMs) in a region of Spain between 2015 and 2019 was analyzed through a population-based registry study. Pharmacy dispensing records for DIMs are provided. The use of DIMs on drivers was weighted according to the national driver’s license census. The analysis was performed considering the population distribution by age and sex, treatment length, and the three DRUID categories. DIMs were used by 36.46% of the population and 27.91% of drivers, mainly chronically, with considerable daily use (8.04% and 5.34%, respectively). Use was more common in females than in males (42.28% vs. 30.44%) and increased with age. Among drivers, consumption decreases after 60 years of age for females and after 75 years of age for males. There was a 34% increase in the use of DIMs between 2015 and 2019, with a focus on daily use (>60%). The general population took 2.27 ± 1.76 DIMs, fundamentally category II (moderate influence on fitness to drive) (20.3%) and category III (severe influence on fitness to drive) (19.08%). The use of DIMs by the general population and drivers is significant and has increased in recent years. The integration of the DRUID classification into electronic prescription tools would assist physicians and pharmacists in providing adequate information to the patient about the effects of prescribed medications on their fitness to drive.
PB MDPI
SN 1424-8247
YR 2023
FD 2023
LK https://uvadoc.uva.es/handle/10324/63801
UL https://uvadoc.uva.es/handle/10324/63801
LA eng
NO Pharmaceuticals, 2023, Vol. 16, Nº. 4, 508
NO Producción Científica
DS UVaDOC
RD 17-may-2024